Finance

Lists
060590:KOSDAQ
CTC Bio Inc
2 740,00 KRW
-0,90%
(-25,00) 1D
20-ноя., 15:30:16 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 060590...
Open
2 780 KRW
High
2 780 KRW
Low
2 635 KRW
Mkt. cap
66,26 млд
Avg. vol.
42,49 миң
Volume
39,60 миң
P/E ratio
8,71
52-wk high
5 610 KRW
52-wk low
2 525 KRW
EPS
314 KRW
Shares outstanding
24,18 млн
No. of employees
226
Open
2 780 KRW
High
2 780 KRW
Low
2 635 KRW
Mkt. cap
66,26 млд
Avg. vol.
42,49 миң
Volume
39,60 миң
P/E ratio
8,71
52-wk high
5 610 KRW
52-wk low
2 525 KRW
EPS
314 KRW
Shares outstanding
24,18 млн
No. of employees
226
News stories
From web sources and news partners
About CTC Bio Inc
CEO-
Employees226
Founded1993
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitectcbio.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
31,62 млд
34,44 млд
33,69 млд
-
Cost of goods sold
18,91 млд
20,10 млд
20,42 млд
19,01 млд
Cost of revenue
18,91 млд
20,10 млд
20,42 млд
-
Research and development expenses
482,35 млн
205,61 млн
198,23 млн
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,29 млд
9,30 млд
8,87 млд
8,58 млд
Operating expense
11,20 млд
9,74 млд
9,48 млд
9,11 млд
Total operating expenses
30,11 млд
29,84 млд
29,89 млд
28,11 млд
Operating income
1,51 млд
4,60 млд
3,79 млд
3,14 млд
Other non operating income
-91,96 млн
-55,25 млн
-271,27 миң
-
EBT including unusual items
-220,58 млн
4,46 млд
3,49 млд
2,19 млд
EBT excluding unusual items
-84,63 млн
4,38 млд
3,38 млд
-
Income tax expense
-1,34 млд
955,92 млн
887,77 млн
-
Effective tax rate
607,65%
21,45%
25,44%
24,17%
Other operating expenses
92,32 млн
34,12 млн
202,89 млн
-
Net income
1,10 млд
3,50 млд
2,60 млд
-
Net profit margin
3,48%
10,16%
7,72%
-
Earnings per share
-
-
-
-
Interest and investment income
94,40 млн
73,22 млн
73,88 млн
-
Interest expense
-569,99 млн
-553,03 млн
-563,90 млн
-
Net interest expenses
-475,58 млн
-479,80 млн
-490,02 млн
-485,08 млн
Depreciation and amortization charges
200,89 млн
174,51 млн
175,71 млн
-
EBITDA
3,11 млд
6,17 млд
5,38 млд
4,75 млд
Gain or loss from assets sale
-132,54 млн
-78,68 млн
-117,11 млн
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору